Study of 4-Aminopyridine Capsules to Help Heal Second-Degree Skin Burns in Adults

What this Trial Is About

Many patients suffer from traumatic burns, and current treatments mainly focus on infection prevention and fluid management without improving the skins ability to regenerate. This research aims to evaluate the role of 4-aminopyridine 4-AP, a promising agent with a good safety profile, in accelerating burn wound healing in patients with second-degree burns. The study addresses the need for new regenerative treatments that can speed up recovery while allowing existing protocols to continue. Participants will be randomly assigned to receive either 4-aminopyridine capsules 10 mg every 12 hours or a placebo capsule on the same schedule. This phase 2 study will compare these two groups over a 12-month period to assess the treatments effect on the healing process. The study uses triple masking to ensure unbiased results. During the study, participants will be monitored for healing rate, skin graft requirements, scar formation, and scar sensitivity over 12 months. They will provide informed consent and attend scheduled follow-up visits where researchers will evaluate wound healing through sensory and motor assessments and calibrated wound photographs. Safety and adherence will be closely tracked to evaluate the treatments impact and patient outcomes throughout the study period.

4-Aminopyridine to Treat Skin Burns